The Estonian Health Insurance Fund invites you to participate in the procurement procedure and submit tenders for the conclusion of a framework contract for the public procurement "Purchase of immunoglobulins and antidotes", which will be carried out in the Public Procurement Register as an e-procurement procedure, the corresponding reference number of the Public Procurement Register is 212444

An antidote with the active substance hydroxocobalamin, 5000mg, infusion powder or other equivalent formulation, treatment of known or suspected cyanide poisoning in patients of all ages. For a total amount of 375 grams (1 vial=5000mg, estimated at 75 vials).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Human rabies immunoglobulin, for post-exposure prophylaxis of rabies in children and adults, in intramuscular (i.m) injectable pharmaceutical form, in a total amount of 9000 IU, 150-300 active substance units (UT) in one vial or other equivalent package.

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Human hepatitis b immunoglobulin for prophylaxis in children and adults, in intramuscular (i.m.) injectable pharmaceutical form, 100-250 active substance units (IU) in one vial or other equivalent package. The total amount should be sufficient for 6 adult individuals, with an average body weight of 80 kg, to carry out full-scale prophylaxis (the total amount is calculated according to the dosage regimen described in the Summary of Product Characteristics for one adult).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Human chickenpox immunoglobulin for prophylaxis in children and adults, in intramuscular (i.m.) injectable pharmaceutical form, üThe total amount should be sufficient for 15 adult people, with an average body weight of 80 kg, to carry out full-scale prophylaxis (the total amount is calculated according to the dosage regimen described in the summary of product characteristics for one adult). The quantity may vary depending on the size of the package offered, but not more than one package offered.

Immunoglobulin is supplied in parts, and for the delivery of each part of the drug volume, the buyer organizes a mini-competition. Exact delivery times, eligibility times, delivery conditions and evaluation conditions for immunoglobulin according to the conditions set out in the mini-competitions and the framework contract.

Botulism antitoxin for the treatment and prophylaxis of botulinum toxin poisoning in children and adults, in intramuscular and intravenous (i.m/i.v) injectable dosage form, in a total amount of 15 full courses of therapy. The quantity may vary depending on the size of the package offered, but not more than one package offered.

Immunoglobulin is supplied in parts, and for the delivery of each part of the drug volume, the buyer organizes a mini-competition. Exact delivery times, eligibility times, delivery conditions and evaluation conditions for immunoglobulin according to the conditions set out in the mini-competitions and the framework contract

Diphtheria antitoxin for prophylaxis in children and adults, in intramuscular (i.m.) injectable dosage form. Total 60 OP.

Antidote with the active substance gastric venom antiserum, 100mg infusion solution powder or other equivalent formulation, treatment of severe or moderate intoxication caused by the bite of a European thrush in patients of all ages. A total of 18 grams (1 vial of 100 mg, estimated at 180 vials).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Antidote with the active substance phomepizole methanol or ethylene glycol poisoning antiserum, 100 mg solution for injection or other equivalent pharmaceutical form, in a total amount of 120 grams (1 vial of 100mg, estimated at 1200 vials).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Antidote silibinin amatoxin antiserum, 340 mg solution for injection or other equivalent formulation, for a total amount of 84 grams (1 vial 350 mg, estimated at 240 vials).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Antidote with the active substance deferoxamine, lyophilized substance 500mg N10 or other equivalent pharmaceutical form, in a total amount of 180 grams (1 OP 5g, estimated at 36 OP).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Antidote with the active substance sodium calcium edetate, solution for injection 500mg/10ml 10ml or other equivalent pharmaceutical form, for a total amount of 150 grams (1 vial of 500mg, estimated at 300 vials).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Antidote with the active substance thief antitoxin, powder for solution for infusion 40mg N1 or other equivalent pharmaceutical form, for a total amount of 8.8 grams (1 OP 40mg, estimated at 220 OP).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Antidote with the active substance 2,3-dimercaptopropanosulfonic acid sodium salt e sodium 2,3-dimercapto-1propane sulfonate, in total for the treatment of 10 people (DMPS dose 15 mg/kg, i.e. treatment of one person 1.2g).

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.

Human tetanus immunoglobulin, post-exposure for the prevention of tetanus in children and adults, in intramuscular (i.m) injectable dosage form, in a total amount of 36000 (6 full-scale courses of treatment) UT, 250 active substance units (UT) in one vial or other equivalent package.

The antidote is supplied in parts, and for the supply of each part of the quantity of the medicinal product, a mini-competition is organized by the buyer. The exact delivery times, eligibility times, delivery conditions and evaluation conditions of the antidote in accordance with the conditions laid down in the mini-competitions and the framework contract.